Results 171 to 180 of about 111,529 (192)

Activation of coagulation by a LDL-apheresis device

Blood Coagulation & Fibrinolysis, 1996
LDL-apheresis often induces an almost constant and progressive increase of the differential pressure of plasma flowing through the dextran sulphate cellulose column, reducing the efficacy of the treatment. On two occasions we were able to identify a fibrin plug by immunofluorescence. Our aim was to verify the modification of some coagulation indicators
C, Giansante, P, Bordin, N, Fiotti, S, Calabrese, A, Petrucco, P G, Da Col, M, Fonda, L, Cattin   +7 more
openaire   +2 more sources

Role of LDL apheresis in the management of hypercholesterolaemia

Transfusion Science, 1993
Abstract It is now established that extracorporeal cholesterol removal is the best means of improving prognosis in patients with homozygous FH and this should be started before atherosclerosis becomes apparent. Anti-human LDL antibodysepharose columns, dextran sulphate-cellulose gel columns and the HELP system are all potent methods of extracorporeal
Y, Kitano, G R, Thompson
openaire   +2 more sources

[LDL apheresis: an update and overview. LDL apheresis in Sardinia, Italy (SMILDLa)].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia, 2012
LDL apheresis (LDLa) is an invasive therapeutic tool to control qualitative and quantitative disorders of lipid metabolism. It is aimed at achieving a metabolic balance in association with lipid-lowering drugs in patients with severe, genetically determined or acquired dyslipidemia who do not reach clinically adequate LDL-cholesterol (LDL-C) levels (
Claudia, Stefanutti, Serafina, Di Giacomo, Claudia, Morozzi   +2 more
openaire   +1 more source

LDL apheresis as it relates to nursing practice

Transfusion and Apheresis Science, 2017
Nurses are an essential partner in the treatment of complex diseases and they have extensive influence on patient outcomes. Connecting a patient to a machine takes courage, skill, and a whole lot of trust. Anyone who has earned the title of "nurse" has shown courage. Skill comes with hours and hours of practice. Trust is earned and ongoing.
openaire   +2 more sources

Long term effect of LDL apheresis in Japan. LDL Apheresis Study Group.

Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology, 1992
LDL-apheresis is introduced in many cases all over Japan. Among them, evaluation of long-term effect on ischemic heart disease (IHD) has made on 10 cases with homozygous familial hypercholesterolemia (FH) and 49 cases with heterozygous FH. As to homozygous FH, 3 patients had angina pectoris. Mean duration of treatment was 26 months (52 treatments). The
C, Naito, A, Yamamoto, Y, Saito, E, Muto, T, Nishide, M, Shinomiya, M, Mukai, S, Tomono, T, Sato, K, Yasuda   +9 more
openaire   +1 more source

Development of Selective Low‐Density Lipoprotein (LDL) Apheresis System: Immobilized Polyanion as LDL‐Specific Adsorption for LDL Apheresis System

Therapeutic Apheresis, 1996
Abstract: Guest Editor's Introduction: The binding site of the human LDL receptor is rich in anionic amino acids, and interacts with apolipoprotein‐B by the electrostatic force. Therefore, anionic ligands could be used for the selective adsorption of LDL without HDL adsorption. Based upon this concept, Kaneka Co. developed LDL adsorbent. The adsorbent
openaire   +2 more sources

LDL APHERESIS AND REGRESSION OF ATHEROSCLEROSIS

The Lancet, 1985
V V, Tertov, Kh A, Khashimov, A N, Orekhov, D N, Mukhin, Kh A, Kurdanov, O M, Chichinadze, S N, Pokrovsky   +6 more
openaire   +2 more sources

LDL Apheresis

2013
Huy P. Pham, Joseph Schwartz
openaire   +1 more source

Treatment methods for LDL apheresis

Journal of Clinical Apheresis, 1994
Andrea Bertrams, Nicholas Strout, Harvey G. Klein   +2 more
openaire   +2 more sources

LDL Apheresis

2019
Monika Paroder-Belenitsky, Huy P. Pham
openaire   +1 more source